Tibet Pharmaceuticals
(OTC) TBET
This security has been delisted. This page is retained for historical reference.
TBET News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowTBET Financials
Key Financial Metrics (TTM)
Gross Margin
49.98%
Operating Margin
41.14%
Net Income Margin
40.61%
Return on Equity
77.26%
Return on Capital
56.70%
Return on Assets
46.61%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
19.12%
Stock Overview
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$14.17M
Operating Income
$10.80M
EBITDA
$11.81M
Operating Cash Flow
$6.03M
Capital Expenditure
-$8.27K
Free Cash Flow
$6.02M
Cash & ST Invst.
$25.96M
Total Debt
$0.00
Tibet Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$8.58M
-4.9%
Gross Profit
$2.95M
-36.8%
Gross Margin
34.31%
N/A
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
N/A
N/A
Employees
190
N/A
Net Income
$1.65M
-57.1%
EBITDA
$2.02M
-53.0%
Quarterly Fundamentals
Total Cash
$25.96M
+210.3%
Total Debt
$0.00
-100.0%
Accounts Receivable
$16.01M
+65.6%
Inventory
$1.74M
-5.6%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$0.00
N/A
Return on Assets
46.61%
N/A
Return on Invested Capital
56.70%
N/A
Free Cash Flow
-$3.79M
-781.7%
Operating Cash Flow
-$3.79M
-779.1%